Search

Displaying results 2381 - 2390 of 2744 in total
  1. Drug

    Telenzepine

    go.drugbank.com/drugs/DB19508
    Investigational

    The usage of the INN stem '-zepine' in the name indicates that Telenzepine is a tricyclic compound.

  2. Drug

    Setileuton

    go.drugbank.com/drugs/DB19550
    Investigational

    The usage of the INN stem '-leuton' in the name indicates that Setileuton is a 5-lipo-oxygenase inhibitor, anti-inflammatory.

  3. Drug

    Felezonexor

    go.drugbank.com/drugs/DB21067
    Investigational

    The usage of the INN stem '-nexor' in the name indicates that Felezonexor is a nuclear export inhibitor.

  4. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor.

  5. Drug

    Edaxeterkib

    go.drugbank.com/drugs/DB21490
    Investigational

    The usage of the INN stem '-terkib' in the name indicates that Edaxeterkib is a extracellular signal-regulated kinase (ERK) inhibitor.

  6. Drug

    Azetukalner

    go.drugbank.com/drugs/DB21551
    Investigational

    The usage of the INN stem '-kalner' in the name indicates that Azetukalner is a opener of calcium-activated (maxi-K) K+-channel.

  7. Drug

    Icovamenib

    go.drugbank.com/drugs/DB21669
    Investigational

    The usage of the INN stem '-menib' in the name indicates that Icovamenib is a menin interaction inhibitor.

  8. Drug

    ReN001

    go.drugbank.com/drugs/DB05236
    Investigational

    ReN001 is a clonal human neural stem cell line developed for clinical use in the treatment of stable disability after stroke.

  9. Drug

    Tozasertib

    go.drugbank.com/drugs/DB19675
    Investigational

    The usage of the INN stem '-sertib' in the name indicates that Tozasertib is a serine/threonine kinase inhibitor.

  10. Drug

    Conteltinib

    go.drugbank.com/drugs/DB21262
    Investigational

    The usage of the INN stem '-tinib' in the name indicates that Conteltinib is a tyrosine kinase inhibitor.